| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871353 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
Definitive chemoradiation therapy is more commonly used than trimodality therapy, but trimodality treatment is associated with excellent survival outcomes on propensity-matched and unmatched survival analysis. Dose escalation beyond 50 Gy remains frequently used but is not associated with a survival benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Meng S. MD, Andrew T. MD, David MD, Joseph P. Weiner, David MD,